Pain News and Research

Latest Pain News and Research

Stress management program may help people with MS prevent new disease activity

A new study shows that taking part in a stress management program may help people with multiple sclerosis (MS) prevent new disease activity. The study is published in the July 11, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

12 Jul 2012

Hearing set for Wednesday on Miss. abortion law

A federal judge today will hear arguments on letting an abortion law in Mississippi go into effect. Opponents say the law could shutter the state's only abortion clinic.

12 Jul 2012

Nonsurgical treatment may be more beneficial for baseball players with SLAP tears

Surgically repairing a painful shoulder injury in baseball players known as a SLAP tear (superior labral) varies widely and often doesn't allow for return to play at the same level as before the injury. However, researchers presenting their findings at the American Orthopaedic Society for Sports Medicine's Annual Meeting in Baltimore, Maryland suggest that nonsurgical treatment may be more beneficial.

12 Jul 2012

Arena files lorcaserin hydrochloride MAA with Swissmedic

Arena Pharmaceuticals, Inc. announced today the filing with the Swiss health authority, Swissmedic, of a Marketing Authorization Application (MAA) for lorcaserin hydrochloride, an investigational drug candidate in Switzerland.

12 Jul 2012

Mindfulness techniques show health benefits

Specific types of "mindfulness practices" including Zen meditation have research-proven benefits for patients with certain physical and mental health problems, according to a report in the July Journal of Psychiatric Practice.

12 Jul 2012

Many abusers switch to heroin due to new formulation of OxyContin

A change in the formula of the frequently abused prescription painkiller OxyContin has many abusers switching to a drug that is potentially more dangerous, according to researchers at Washington University School of Medicine in St. Louis.

12 Jul 2012

U.K. High Court rules in favor of Teva in COPAXONE patent litigation

Teva Pharmaceutical Industries Ltd. announced that the United Kingdom High Court of Justice issued a decision in favor of Teva in a patent litigation proceeding against Generics (UK) Limited, a subsidiary of Mylan Laboratories Inc., on July 11, 2012.

12 Jul 2012

Enrollment complete in Phase III IND study of Spinal Restoration's Biostat System

Spinal Restoration, Inc. announced today the completion of enrollment in the Phase III Investigational New Drug (IND) study of the Biostat System. The Phase III clinical trial is a 260-subject, randomized, blinded, placebo controlled study designed to assess the ability of the Biostat System to reduce pain and improve function in patients with chronic discogenic low back pain.

12 Jul 2012

Dolutegravir-based regimen demonstrates superiority over Atripla in treatment-naive adults with HIV-1

Shionogi-ViiV Healthcare LLC today announced that initial results have been received from the Phase III SINGLE (ING114467) study of the investigational integrase inhibitor dolutegravir in treatment-naive adults with HIV-1.

12 Jul 2012

Pain rehab may boost children’s ownership of self management

Pediatric pain rehabilitation may lead to an increased willingness to self-manage pain, which is associated with improvements in function and psychologic wellbeing, say researchers.

11 Jul 2012

DRCRF names 21 new Damon Runyon Fellows

The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting innovative early career researchers, named 21 new Damon Runyon Fellows at its spring Fellowship Award Committee review.

11 Jul 2012

Agencies place unqualified, possibly criminal caregivers in homes of vulnerable seniors

If you hire a caregiver from an agency for an elderly family member, you might assume the person had undergone a thorough criminal background check and drug testing, was experienced and trained for the job.

11 Jul 2012

Activity levels best reflect functional capacity of back pain patients

The level of physical activity displayed by an elderly individual with chronic low back pain is a better predictor for functional capacity than psychosocial factors, results from a community-based study indicate.

10 Jul 2012

Efficacy of steroids for heel pain confirmed

The efficacy of a single steroid injection for plantar fasciitis has been proven over placebo in one of the few controlled trials of the treatment.

10 Jul 2012

Depressed patients need the right kind of support

Clinicians should be aware of the potential detrimental effects the behavior of family and friends can have on depressed individuals, report US researchers.

10 Jul 2012

Photodynamic therapy promising after failed chemo for ESCC

Photodynamic therapy is a potentially curative and tolerable salvage treatment option for patients with esophageal squamous cell carcinoma when chemoradiotherapy has failed, report researchers.

10 Jul 2012

TV news coverage makes painful viewing

Patients with existing chronic pain syndromes experience a significant increase in pain when they are exposed to media coverage of terrorist missile attacks, researchers say.

10 Jul 2012

Radiotherapy redundant in low-risk Hodgkin lymphoma treatment

Children with low-risk Hodgkin lymphoma who respond well to chemotherapy may not require additional radiotherapy, suggest study results.

10 Jul 2012

$Vertebral fracture more common among Chinese women than men$

Vertebral fracture more common among Chinese women than men

Vertebral deformities occur at a similar rate among Chinese men and women aged 65 years or older, research findings show.

10 Jul 2012

ACADI’s pimavanserin may have therapeutic benefits in treatment of ADP

ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced results of preclinical studies, which suggest that pimavanserin, ACADIA's proprietary product candidate currently in Phase III development for Parkinson's disease psychosis, also may have therapeutic benefits in the treatment of Alzheimer's disease psychosis (ADP).

10 Jul 2012